Literature DB >> 25745187

The efficacy of ibrutinib in the treatment of Richter syndrome.

Mazie Tsang1, Tait D Shanafelt1, Timothy G Call1, Wei Ding1, Asher Chanan-Khan2, Jose F Leis3, Grzegorz S Nowakowski1, Deborah Bowen1, Michael Conte1, Susan M Schwager1, Susan L Slager4, Neil E Kay1, Curtis A Hanson5, Sameer A Parikh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25745187      PMCID： PMC4351511          DOI： 10.1182/blood-2014-12-610782

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  How we treat Richter syndrome.

Authors:  Sameer A Parikh; Neil E Kay; Tait D Shanafelt
Journal:  Blood       Date:  2014-01-13       Impact factor: 22.113

2.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

3.  Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.

Authors:  Ekaterina Chigrinova; Andrea Rinaldi; Ivo Kwee; Davide Rossi; Paola M V Rancoita; Jonathan C Strefford; David Oscier; Kostas Stamatopoulos; Theodora Papadaki; Francoise Berger; Ken H Young; Fiona Murray; Richard Rosenquist; Timothy C Greiner; Wing C Chan; Ester M Orlandi; Marco Lucioni; Roberto Marasca; Giorgio Inghirami; Marco Ladetto; Francesco Forconi; Sergio Cogliatti; Hana Votavova; Steven H Swerdlow; Stephan Stilgenbauer; Miguel A Piris; Andras Matolcsy; Dominic Spagnolo; Eugene Nikitin; Alberto Zamò; Valter Gattei; Govind Bhagat; German Ott; Emanuele Zucca; Gianluca Gaidano; Francesco Bertoni
Journal:  Blood       Date:  2013-09-04       Impact factor: 22.113

4.  Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.

Authors:  Anas Younes; Catherine Thieblemont; Franck Morschhauser; Ian Flinn; Jonathan W Friedberg; Sandy Amorim; Benedicte Hivert; Jason Westin; Jessica Vermeulen; Nibedita Bandyopadhyay; Ronald de Vries; Sriram Balasubramanian; Peter Hellemans; Johan W Smit; Nele Fourneau; Yasuhiro Oki
Journal:  Lancet Oncol       Date:  2014-07-17       Impact factor: 41.316

5.  Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation.

Authors:  Kate Cwynarski; Anja van Biezen; Liesbeth de Wreede; Stephan Stilgenbauer; Donald Bunjes; Bernd Metzner; Vladimir Koza; Mohamad Mohty; Kari Remes; Nigel Russell; Arnon Nagler; Marijke Scholten; Theo de Witte; Anna Sureda; Peter Dreger
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

6.  Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.

Authors:  Apostolia-Maria Tsimberidou; Susan O'Brien; Issa Khouri; Francis J Giles; Hagop M Kantarjian; Richard Champlin; Sijin Wen; Kim-Anh Do; Susan C Smith; Susan Lerner; Emil J Freireich; Michael J Keating
Journal:  J Clin Oncol       Date:  2006-05-20       Impact factor: 44.544

7.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

8.  Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

Authors:  John C Byrd; Jennifer R Brown; Susan O'Brien; Jacqueline C Barrientos; Neil E Kay; Nishitha M Reddy; Steven Coutre; Constantine S Tam; Stephen P Mulligan; Ulrich Jaeger; Steve Devereux; Paul M Barr; Richard R Furman; Thomas J Kipps; Florence Cymbalista; Christopher Pocock; Patrick Thornton; Federico Caligaris-Cappio; Tadeusz Robak; Julio Delgado; Stephen J Schuster; Marco Montillo; Anna Schuh; Sven de Vos; Devinder Gill; Adrian Bloor; Claire Dearden; Carol Moreno; Jeffrey J Jones; Alvina D Chu; Maria Fardis; Jesse McGreivy; Fong Clow; Danelle F James; Peter Hillmen
Journal:  N Engl J Med       Date:  2014-05-31       Impact factor: 91.245

9.  Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

Authors:  John C Byrd; Richard R Furman; Steven E Coutre; Ian W Flinn; Jan A Burger; Kristie A Blum; Barbara Grant; Jeff P Sharman; Morton Coleman; William G Wierda; Jeffrey A Jones; Weiqiang Zhao; Nyla A Heerema; Amy J Johnson; Juthamas Sukbuntherng; Betty Y Chang; Fong Clow; Eric Hedrick; Joseph J Buggy; Danelle F James; Susan O'Brien
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245
  9 in total
  23 in total

Review 1.  The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia.

Authors:  Adrian Wiestner
Journal:  Haematologica       Date:  2015-12       Impact factor: 9.941

Review 2.  Richter transformation in the era of novel agents.

Authors:  Wei Ding
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy.

Authors:  Alankrita Taneja; Jade Jones; Stefania Pittaluga; Irina Maric; Mohammed Farooqui; Inhye E Ahn; Adrian Wiestner; Clare Sun
Journal:  Leuk Lymphoma       Date:  2018-07-06

4.  Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study.

Authors:  Samantha M Jaglowski; Jeffrey A Jones; Veena Nagar; Joseph M Flynn; Leslie A Andritsos; Kami J Maddocks; Jennifer A Woyach; Kristie A Blum; Michael R Grever; Kelly Smucker; Amy S Ruppert; Nyla A Heerema; Gerard Lozanski; Mona Stefanos; Brian Munneke; Jamie-Sue West; Jutta K Neuenburg; Danelle F James; Nathan Hall; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2015-06-26       Impact factor: 22.113

5.  Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.

Authors:  Alex F Herrera; Kwang Woo Ahn; Carlos Litovich; Yue Chen; Amer Assal; Qaiser Bashir; Ruthee-Lu Bayer; Melanie Coleman; Zachariah DeFilipp; Nosha Farhadfar; Matthew Greenwood; Theresa Hahn; Mitchell Horwitz; Caron Jacobson; Samantha Jaglowski; Sylvie Lachance; Amelia Langston; Bassam Mattar; Richard T Maziarz; Joseph McGuirk; Mohammad A H Mian; Sunita Nathan; Adrienne Phillips; Kevin Rakszawski; Henrik Sengeloev; Shalini Shenoy; Robert Stuart; Craig S Sauter; Mohamed A Kharfan-Dabaja; Mehdi Hamadani
Journal:  Blood Adv       Date:  2021-09-28

Review 6.  The potential of pirtobrutinib in multiple B-cell malignancies.

Authors:  Jeffrey L Jensen; Anthony R Mato; Camila Pena; Lindsey E Roeker; Catherine C Coombs
Journal:  Ther Adv Hematol       Date:  2022-06-16

Review 7.  Richter's Transformation.

Authors:  Audrey M Sigmund; Adam S Kittai
Journal:  Curr Oncol Rep       Date:  2022-04-06       Impact factor: 5.945

Review 8.  Ibrutinib: from bench side to clinical implications.

Authors:  Davide Grisafi; Alessandra Maestro; Camilla Grumi; Ludovica Piazzoni; Giampaolo Tirone; Walter Fiore; Roberto Tessari; Valeria Gianardi; Milo Gatti; Francesca Tasca; Daniele Generali; Andrea Ravelli; Francesco Lanza; Francesco Scaglione
Journal:  Med Oncol       Date:  2015-07-30       Impact factor: 3.064

Review 9.  Treatment of Richter's Syndrome.

Authors:  Adalgisa Condoluci; Davide Rossi
Journal:  Curr Treat Options Oncol       Date:  2017-11-21

10.  Richter Syndrome in Chronic Lymphocytic Leukemia.

Authors:  Candida Vitale; Alessandra Ferrajoli
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.